Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2022

2019

2012

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Antigens, Differentiation, B-Lymphocyte""[mesh_terms]

6 Results

Searching titles within these results

Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.

Jan Sedlak, Ladislav Novotny, Thomas Szekeres

Current medicinal chemistry 2002;9(7):759-64

Full Text

Abstract

Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.

Cristina Chiva, Philippe Barthe, Anna Codina, Margarida Gairí, Franck Molina, Claude Granier, Martine Pugnière, Tatsuya Inui, Hideki Nishio, Yuji Nishiuchi, Terutoshi Kimura, Shumpei Sakakibara, Fernando Albericio, Ernest Giralt

Journal of the American Chemical Society 2003;125(6):1508-17

Full Text

Abstract

TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.

Ryohei Katayama, Naoya Fujita, Takeshi Tomonaga, Jun Adachi, Yuka Nagatake-Kobayashi, Hayato Ogura

Scientific reports 2019;7(1):5519

Free Full Text

Abstract

Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.

M Y Pushkareva, S L Wannberg, A S Janoff, E Mayhew

Cancer immunology, immunotherapy : CII 2000;48(10):569-78

Free Full Text

Abstract

2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials.

B Fernández Fernández, U Elewa, M D Sánchez-Niño, J E Rojas-Rivera, C Martin-Cleary, J Egido, A Ortiz

Minerva medica 2012;103(4):219-34

Full Text

Abstract

Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in Fusion-Positive Lung Cancer.

Jessica J Lin, Noura J Choudhury, Satoshi Yoda, Viola W Zhu, Ted W Johnson, Ramin Sakhtemani, Ibiayi Dagogo-Jack, Subba R Digumarthy, Charlotte Lee, Andrew Do, Jennifer Peterson, Kylie Prutisto-Chang, Wafa Malik, Harper G Hubbeling, Adam Langenbucher, Adam J Schoenfeld, Christina J Falcon, Jennifer S Temel, Lecia V Sequist, Beow Y Yeap, Jochen K Lennerz, Alice T Shaw, Michael S Lawrence, Sai-Hong Ignatius Ou, Aaron N Hata, Alexander Drilon, Justin F Gainor

Clinical cancer research : an official journal of the American Association for Cancer Research 2022;27(10):2899-2909

Free Full Text

Abstract

Results: 1 – 6 / 6

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Antigens, Differentiation, B-Lymphocyte""[mesh_terms]

Benzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.

Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.

TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.

Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.

2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials.

Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in Fusion-Positive Lung Cancer.

Results for

""Antigens, Differentiation, B-Lymphocyte""[mesh_terms]